Letter to the Editor

Red Cell Width: An Emerging and Novel Biomarker of Systemic Inflammation

Authors: Sarah Jaroudi, BS, Ahmad Alazzeh, MD, Alan N. Peiris, MD, PhD, FRCP(London)

Abstract

To the Editor: Systemic inflammation has been implicated in the etiology of many diseases and is often linked to poor health outcomes. Several indices have been used as markers for such inflammation.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Salvagno GL, Sanchis-Gomar F, Picanza A, et al. Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci 2015;52:86-105.
 
2. Hu ZD. Red blood cell distribution width: a promising index for estimating activity of autoimmune disease. J Lab Precis Med 2016;1:4-4.
 
3. He W, Jia J, Chen J, et al. Comparison of prognostic value of red cell distribution width and NT-proBNP for short-term clinical outcomes in acute heart failure patients. Int Heart J 2014;55:58-64.
 
4. Lippi G, Targher G, Salvagno GL, et al. Increased red blood cell distribution width (RDW) is associated with higher glycosylated hemoglobin (HbA1c) in the elderly. Clin Lab 2014;60:2095-2098.
 
5. Fici F, Celik T, Balta S, et al. Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension. J Cardiovasc Pharmacol 2013;62:388-393.